Identification of a thrombin cleavage site and a short form of ADAMTS-18

We previously reported that C-terminal fragment of ADAMTS-18 induces platelet fragmentation through ROS release. We have shown that thrombin cleaves ADAMTS-18 and that a short form of ADAMTS-18 in in vitro translational assay. However, the exact thrombin cleavage site and whether a short form ADAMTS-18 presents in vivo are not clear. In this study, we first identified that the thrombin cleavage site is between Arg775 and Ser776 by thrombin cleavage of ADAMTS-18 peptide following mass spectrum assay. We then showed that a short form ADAMTS-18 presents in brain, kidney, lung, and testicle from C57BL/6 mouse embryo. Since alternative form of ADAMTS-18 could be a mechanism to regulate its activity, we then investigated the mechanism involves in the generation of ADAMTS-18 short form. However, neither protease inhibitors nor mutations in catalytic domain of ADAMTS-18 have any significant effect on the generation of ADAMTS-18 short form. Thus, our data demonstrate a thrombin cleavage site and confirm a short form of ADAMTS-18 presents in vivo.     

Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin

We have described an autoantibody against beta3 (GPIIIa49-66), a region of platelet integrin alphaIIbbeta3 that is unique. It induces platelet fragmentation in the absence of complement via antibody activation of platelet NADPH oxidase and 12-lipoxygenase to release reactive oxygen species, which destroy platelets. To study the mechanism of anti-GPIIIa antibody-induced platelet fragmentation, we screened a human single chain Fv antibody library with the GPIIIa49-66 peptide. Nine monoclonal antibodies were identified that were capable of binding to GPIIIa49-66. Surprisingly, binding avidity for GPIIIa49-66 did not correlate with activity of induction of platelet fragmentation. We therefore investigated the requirements for platelet fragmentation. Mutations were introduced into the heavy chain complementary-determining region-3 of clones 11, 43, and 54 by site-directed mutagenesis. The capability of these clones to induce platelet fragmentation or bind to GPIIIa49-66 subsequently changed. Molecular modeling of these clones with their mutants revealed that the ability to induce platelet fragmentation is affected by the side chain orientation of positively charged amino acids in the heavy chain of residues 99-102. Thus, a structural change in the conformation of anti-GPIIIa49-66 antibody contributes to its binding to the beta3 integrin and subsequent antibody-induced platelet fragmentation and aggregate dissolution.     

UV-B辐射对植物花粉萌发率和花粉管生长的累积效应

研究了19种植物花粉在不同UV－B辐射强度和辐照时间下其萌发率和花粉管伸长的变化,结果表明,UV－B辐射增加显著抑制大多数植物花粉的萌发率和花粉管生长;与对照相比,较高强度的UV－B对花粉的抑制作用大于较低强度;几个种的花粉萌发率及花粉管生长对UV－B增强不敏感,甚至被UV－B辐射所促进;辐射时间越长,对花粉抑制作用愈大,说明具有辐射累积效应,由此可知,植物花粉的萌发过程对UV－B的敏感性变化在自然条件下将会产生严重的生态学后果。     

增强UV-B辐射对大豆胚轴DNA损伤、修复和蛋白质含量的影响

大气平流层臭氧层减薄引起到达地表的 UV- B辐射增强。为探讨在增强 UV- B辐射下植物细胞 DNA的损伤修复和蛋白质含量的关系 ,利用 3H- Td R掺入法 ,研究了在 8.2 2 k J/(m2 d)和 12 .4 2 k J/(m2 d) U V- B辐射 (相当于兰州地区大气平流层臭氧减薄约 12 %和 2 0 % )胁迫下 ,大豆胚轴细胞 DNA合成和非按期合成 (UDS)变化 ,并测定了胚轴蛋白质含量变化 ,结果显示 ,UV- B辐射导致 DNA损伤 ,并诱导了 DNA损伤的修复 ,胚轴细胞 UDS效应增强 ,U DS指数增大。低 UV- B辐射强度下 ,胚轴蛋白质含量增加 ,可能是 U V- B诱导了一些与抗性有关的基因表达 ,导致一些新的与抗性有关的蛋白质合成 ;在高强度 UV- B辐射下 ,U DS指数与低强度辐射下无显著差异 (P=0 .0 5 ) ,但蛋白含量较低强度辐射下显著下降 (P=0 .0 5 ) ,说明高强度 UV- B辐射加重了 DNA损伤 ,而修复并未加强 ,并且高强度辐射抑制基因的正常表达和蛋白质合成。这些蛋白质的合成可能与大豆对 UV- B辐射的抗性有关。